AUTOTAC BIO
AUTOTAC Bio is a drug development company that creates protein target decomposition drugs for humans.
AUTOTAC BIO
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.autotacbio.com
Total Employee:
11+
Status:
Active
Contact:
+82 02 6951 1448
Email Addresses:
[email protected]
Total Funding:
16.5 M USD
Similar Organizations
Aging Target
Aging Target is a medical research and development company that generates medicine for age-related diseases.
AnnJi Pharmaceutical
AnnJi Pharmaceutical is a drug development company that produces small molecules for neurology, dermatology, and inflammatory disorders.
Intec Pharma
Intec Pharma is a drug development company that applies gastric retention technology to develop improved formulations of existing drugs.
Naturewise Biotech & Medicals Corp
Naturewise Biotech & Medicals Corp is a drug development company which focuses research on the botanical drug and small molecule therapies.
PhytoHealth
PhytoHealth is a drug development company that works to develop new drugs in compliance with international standards and regulations.
Protekt Therapeutics
Protekt Therapeutics is a drug development company aiming to develop inhibitors of PKR for various diseases
RIBOMIC
R&D medicine based on their own platform for developing medicine
Investors List
Dayli Partners
Dayli Partners investment in Series B - AUTOTAC Bio
Shinhan Venture Investment
Shinhan Venture Investment investment in Series B - AUTOTAC Bio
Aju IB Investment
Aju IB Investment investment in Series B - AUTOTAC Bio
Official Site Inspections
http://www.autotacbio.com
- Host name: 183.111.169.45
- IP address: 183.111.169.45
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "AUTOTAC Bio"
AUTOTAC Bio
Organization AUTOTAC Bio has a systematic structure to lead the bio industry and moves toward its goal. Address. 5 Th floor, 254, Changgyeonggung-ro, Jongno-gu, Seoul, Republic of KoreaSee details»
AUTOTAC Bio - Crunchbase Company Profile & Funding
Organization. AUTOTAC Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
Autotac Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Www.autotacbio.com. Startups | Holding Company | 2015 | Seoul, South Korea | 10-50 | www.autotacbio.com. Last update 06 Mar 2025. Overview. Pipeline. Deal. Translational …See details»
Autotac Bio 2025 Company Profile: Valuation, Funding …
Autotac Bio General Information Description. Developer of protein target decomposition drugs intended to develop therapeutics for humans. The …See details»
AUTOTAC Bio Inc. - VentureRadar
AUTOTACBio, We challenge to create the new modality for target protein degradation platform technology using AUTOTAC(Autophagy-Targeting Chimera). Through this platform we are …See details»
AUTOTAC BIO Inc. | LinkedIn
Chang Hoon Ji Executive Director at AUTOTAC Bio, Inc. & Research Assistant Professor at Seoul National UniversitySee details»
AUTOTAC Bio
Disease Areas Metabolic Diseases. By synthetically activating lipophagy, our ATL compounds can promote intrinsic breakdown of fatty lipids and glucose level regulation and thereby treat …See details»
Autotac Bio. Inc. - BioCentury Company Profiles - BCIQ
Aug 16, 2022 Autotac Bio. Inc. - BioCentury Company Profiles for the biopharma industrySee details»
AUTOTAC Bio - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Apr 10, 2020: Series B - …See details»
Autotacbio.com - Company Profile - Tracxn
Autotacbio.com - Provider of technology for the protein metabolism and N- terminal degradation pathway for drug development. from 3 investors. Autotacbio.com has 2876 competitors.See details»
AUTOTAC Bio - Portfolio Company Profile, Executives and Private …
See AUTOTAC Bio's complete profile, including its private equity owner and the number of its executive contacts in our database. AUTOTAC is a new drug development company based on …See details»
Autotac Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Sep 7, 2024 Explore Autotac Bio, Inc. with its drug pipeline, therapeutic area, technology platform, 15 literature, Disease Domain:Neoplasms, Nervous System Diseases ...See details»
Autotac Bio - Products, Competitors, Financials, Employees ...
This strategic partnership strengthens New Charter's position as a national network of top-tier IT service providers, combining local expertise with the power of a larger, collaborative …See details»
Autotac Bio, Inc. (Autotac Bio, Inc.) - 药物管线_专利_临床试验_投融 …
了解Autotac Bio, Inc. (Autotac Bio, Inc.)公司的药物管线，治疗领域，技术平台，以及它的17篇文献，疾病领域:神经系统疾病，内分泌与代谢疾病，肿瘤，感染，技术平台:AUTOTAC，偶联 …See details»
AUTOTAC Bio
Address. 5 Th floor, 254, Changgyeonggung-ro, Jongno-gu, Seoul, Republic of Korea Tel. 02-6951-1448 E-mail. [email protected]See details»
AUTOTAC-动脉网 - vbdata.cn
[email protected] AUTOTAC Bio是一家基于AUTOTAC（自噬靶向嵌合体）蛋白质靶标分解平台技术的新药开发公司。 AUTOTAC是下一代新药开发平台技术，可以选择性地将各种致病 …See details»
Invest In AUTOTAC Bio Stock | Buy Pre-IPO Shares | EquityZen
Dec 10, 2024 Join now and verify your accreditation status to gain access to: AUTOTAC Bio Current Valuation; AUTOTAC Bio Stock Price; AUTOTAC Bio Management; Available deals in …See details»
AUTOTAC Bio
Overview. AUTOTAC Bio focuses on disease material target decomposition for a healthier life.; AUTOTAC Bio is a new drug development company based on AUTOTAC (Autophagy …See details»
AUTOTAC Bio
08 2021.06 ’13 method for regulating p62 zz domain-mediated autophagy and use the.. ’13 method for regulating p62 zz domain-mediated autophagy and use thereof (kr, wo)the present …See details»
AUTOTAC Bio
’19 NOVEL AUTOPHAGY-TARGETING CHIMERA (AUTOTAC) COMPOUND, AND COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING DISEASES THROUGH …See details»